Pharma Markets

US Influenza Market Analysis and Competitive Landscape Highlights

By Fore Pharma | Published Date: May 24, 2020 | On-Demand Data

US Influenza Market Analysis and Competitive Landscape Highlights – 2020, provides comprehensive insights into Influenza pipeline products, Influenza epidemiology, Influenza market valuations and forecast, Influenza drugs sales and competitive landscape in the US.

Research Scope:

– Influenza Pipeline: Drugs in clinical trials for the treatment of Influenza by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
– Influenza Epidemiology: Number of patients diagnosed (prevalence) with Influenza in the US
– Drugs sales: Sales revenues for Influenza drugs in the US
– Market valuations: US Influenza market size for in 2019; find out how the market advanced from 2016 and forecast to 2025
– Drugs market share: Market shares for key Influenza drugs in the US

This research helps executives to

– Support monitoring and reporting national Influenza market analysis and sales trends
– Track competitor drugs sales and market share in the US Influenza market
– Track competitive developments in Influenza market and present key issues and learnings
– Synthesize insights for Influenza market and products to drive business performance
– Answer key business questions about the Influenza market
– Evaluate commercial market opportunity assessment, positioning, and segmentation for Influenza products
– Supports decision making in R&D to long term marketing strategies

Table of Contents


1) Influenza Treatments
2) Influenza Drugs Pipeline
3) US Influenza Epidemiology
4) Marketed Drugs for Influenza in the US
5) Influenza Market Size and Forecast
6) Influenza Drugs Sales and Forecast
7) Influenza Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables


1. Influenza Phase 3 Clinical Trials, 2020
2. Influenza Phase 2 Clinical Trials, 2020
3. Influenza Phase 1 Clinical Trials, 2020
4. Influenza Epidemiology, US, 2016 – 2025
5. Marketed Drugs for Influenza, US, 2019
6. Influenza Market Size and Forecast ($mn), US, 2016 – 2025
7. Influenza Drugs Sales ($mn), US, 2016 – 2025

List of Figures


1. Influenza Epidemiology, US, 2016 – 2025
2. Influenza Market Size and Forecast ($mn), US, 2016 – 2025
3. Influenza Drugs Market Share (%), US, 2019

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies